#FutureReadyHealthcare
Indegene helps top 20 pharma company ‘shift right’ on the material review maturity curve
Challenges
1.5X growth in assets, especially in digital formats, for a span of 2 years. The average time to market had increased by 40% for the same period
Nonstandard process and varying degree of material review maturity across brands and affiliates
Sparse tracking of metrics and limited visibility into process curtailing ability to manage agency performance and optimize MLR operations
The Solution
Extensive as is process study-through stakeholder interviews and analysis of review platform data; identified bottlenecks, gaps, and sources of compliance risks
Tier-based review approach based on content risk profiles, avoiding every asset going through the same level of review
AI/ML-assisted reviews to enhance reviewer productivity, introducing pre-and post-MLR stages to reduce the burden of non-core activity on reviewers
Comprehensive KPI framework for analytics based governance and implemented phased training and change management for material review stakeholders
Outcomes
Our client was able to streamline material review process, improve agency performance (first time rights, adherence to SLAs, and submission guidelines), and harmonize global to affiliate process flow
~45%
Improvement in material review cycle time
20%
Reduction in cost/asset
7000
Person-hours saved in process and tech
Let’s partner for #FutureReadyHealthcare
© 2023 Indegene. All Rights Reserved.
